Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma

M. Schlumberger, R. Elisei, S. Müller, P. Schöffski, M. Brose, M. Shah, L. Licitra, J. Krajewska, M. C. Kreissl, B. Niederle, E. E.W. Cohen, L. Wirth, H. Ali, D. O. Clary, Y. Yaron, M. Mangeshkar, D. Ball, B. Nelkin, S. Sherman